Summit Therapeutics has filed a notice of an exempt offering of securities to raise $199,999,998.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Summit Therapeutics is raising up to $199,999,998.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Manmeet Soni played a…